In Vitro Toxicology Market - Trends Forecast Till 2028

Market Overview

Global in Vitro Toxicology market is anticipated to reach USD 10.8 billion in 2021 growing at a CAGR of 11.5% during the forecasting period, 2021-2028.

In vitro toxicology is a set of technique used to study and identify the effect of various toxins on bacteria and other organisms. As a result of these testing only a drug or chemical is verified for human use. There are various methods like cytotoxicity, toxicokinetics etc. It also leads to develop a dose response relationship.

With an increased research in the sector along with the recent opposition to animal testing are some of the factors that have supported long-term expansion for In Vitro Toxicology industry.

Key Findings

Global In Vitro Toxicology market is segmented into Product, Toxicity Endpoints, Industry and geography.

Product segment is segmented into Assay (Western Blot, Tissue Culture), Equipment, Assay Reagent, and Software

Toxicity Endpoints segment is segmented into ADME, Skin Irritation, Corrosion

Industry segment is segmented into Pharmaceutical, Cosmetics

Geographically, global In Vitro Toxicology market is sub segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America and insights are provided for each region and major countries within the regions

Competitive Landscape

Key players in global In Vitro Toxicology market are Thermo Fisher Scientific Inc. (US), Eurofins Scientific SE (Luxembourg), Covance (US), Bio-Rad Laboratories, Inc. (US), GE Healthcare (US), Merck KGaA (Germany), Charles River Laboratories International, Inc. (US), Catalent, Inc. (US), Cyprotex (UK), SGS S.A. (Switzerland), BioRad Laboratories, QIAGEN N.V. (Germany), Promega Corporation (US), Gentronix Limited (UK), BioIVT (US), MB Research Laboratories (US), Creative Biolabs(US), GVK Biosciences Private Limited (India), Shanghai Medicon Inc (China), Creative Biorray (US) and  Insphero (Switzerland) among others.

Reasons to Acquire

• Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors
• Gain authentic and granular data access for In Vitro Toxicology market so as to understand the trends and the factors involved behind changing market situations
• Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
• In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Report Scope